Khaldoun G Tarakji

Summary

Affiliation: Cleveland Clinic Foundation
Country: USA

Publications

  1. doi request reprint Cardiac implantable electronic device infections: presentation, management, and patient outcomes
    Khaldoun G Tarakji
    Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Heart Rhythm 7:1043-7. 2010
  2. doi request reprint Worldwide Randomized Antibiotic EnveloPe Infection PrevenTion Trial (WRAP-IT)
    Khaldoun G Tarakji
    Section of Electrophysiology and Pacing, Cleveland Clinic, Cleveland, OH Electronic address
    Am Heart J 180:12-21. 2016
  3. doi request reprint Risk factors for 1-year mortality among patients with cardiac implantable electronic device infection undergoing transvenous lead extraction: the impact of the infection type and the presence of vegetation on survival
    Khaldoun G Tarakji
    Section of Cardiac Pacing and Electrophysiology, Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, 9500 Euclid Avenue J2 2, Cleveland, OH, Canada 44195
    Europace 16:1490-5. 2014
  4. doi request reprint Using a novel wireless system for monitoring patients after the atrial fibrillation ablation procedure: the iTransmit study
    Khaldoun G Tarakji
    Section of Cardiac Pacing and Electrophysiology, Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio Electronic address
    Heart Rhythm 12:554-9. 2015
  5. doi request reprint Management of cardiac implantable electronic device infections: the challenges of understanding the scope of the problem and its associated mortality
    Khaldoun G Tarakji
    Section of Cardiac Pacing and Electrophysiology, Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Cleveland Clinic, 9500 Euclid Avenue J2 2, Cleveland, OH 44195, USA
    Expert Rev Cardiovasc Ther 11:607-16. 2013
  6. doi request reprint Clinical predictors of adverse patient outcomes in an experience of more than 5000 chronic endovascular pacemaker and defibrillator lead extractions
    Michael P Brunner
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio
    Heart Rhythm 11:799-805. 2014
  7. doi request reprint Long-term outcomes and clinical predictors for pacemaker-requiring bradyarrhythmias after cardiac transplantation: analysis of the UNOS/OPTN cardiac transplant database
    Daniel J Cantillon
    Cardiovascular Medicine Electrophysiology, Cleveland Clinic, Heart and Vascular Institute, Cleveland, Ohio 44195, USA
    Heart Rhythm 7:1567-71. 2010
  8. doi request reprint Incidence, management, and outcomes of the arteriovenous fistula complicating transvenous lead extraction
    Edmond M Cronin
    Section of Electrophysiology and Pacing, Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland, Ohio
    Heart Rhythm 11:404-11. 2014
  9. ncbi request reprint Incidence, indications, risk factors, and survival of patients undergoing cardiac implantable electronic device implantation after open heart surgery
    Newton B Wiggins
    Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Cleveland Clinic, Sydell and Arnold Miller Heart and Vascular Institute, 9500 Euclid Avenue, Mail Code J3, Cleveland, OH 44195, USA
    Europace . 2016
  10. doi request reprint Transvenous extraction of implantable cardioverter-defibrillator leads under advisory--a comparison of Riata, Sprint Fidelis, and non-recalled implantable cardioverter-defibrillator leads
    Michael P Brunner
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio
    Heart Rhythm 10:1444-50. 2013

Collaborators

Detail Information

Publications15

  1. doi request reprint Cardiac implantable electronic device infections: presentation, management, and patient outcomes
    Khaldoun G Tarakji
    Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Heart Rhythm 7:1043-7. 2010
    ..Indications for cardiac implantable electronic devices (CIEDs) are increasing. Although CIED infections occur infrequently, the impact of this outcome is expected to be substantial...
  2. doi request reprint Worldwide Randomized Antibiotic EnveloPe Infection PrevenTion Trial (WRAP-IT)
    Khaldoun G Tarakji
    Section of Electrophysiology and Pacing, Cleveland Clinic, Cleveland, OH Electronic address
    Am Heart J 180:12-21. 2016
    ..The aim of this study is to determine whether Medtronic TYRX absorbable envelope reduces the risk of CIED infection through 12 months of follow-up post procedure...
  3. doi request reprint Risk factors for 1-year mortality among patients with cardiac implantable electronic device infection undergoing transvenous lead extraction: the impact of the infection type and the presence of vegetation on survival
    Khaldoun G Tarakji
    Section of Cardiac Pacing and Electrophysiology, Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, 9500 Euclid Avenue J2 2, Cleveland, OH, Canada 44195
    Europace 16:1490-5. 2014
    ..We aimed to assess risk factors for 1-year mortality among patients with CIED infection and to evaluate if the type of infection and the presence of vegetation affect survival...
  4. doi request reprint Using a novel wireless system for monitoring patients after the atrial fibrillation ablation procedure: the iTransmit study
    Khaldoun G Tarakji
    Section of Cardiac Pacing and Electrophysiology, Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio Electronic address
    Heart Rhythm 12:554-9. 2015
    ..A novel technology incorporates electrodes into an iPhone case that records an electrocardiographic tracing...
  5. doi request reprint Management of cardiac implantable electronic device infections: the challenges of understanding the scope of the problem and its associated mortality
    Khaldoun G Tarakji
    Section of Cardiac Pacing and Electrophysiology, Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Cleveland Clinic, 9500 Euclid Avenue J2 2, Cleveland, OH 44195, USA
    Expert Rev Cardiovasc Ther 11:607-16. 2013
    ....
  6. doi request reprint Clinical predictors of adverse patient outcomes in an experience of more than 5000 chronic endovascular pacemaker and defibrillator lead extractions
    Michael P Brunner
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio
    Heart Rhythm 11:799-805. 2014
    ..It is difficult to predict adverse patient outcomes associated with transvenous lead extraction (TLE) procedures...
  7. doi request reprint Long-term outcomes and clinical predictors for pacemaker-requiring bradyarrhythmias after cardiac transplantation: analysis of the UNOS/OPTN cardiac transplant database
    Daniel J Cantillon
    Cardiovascular Medicine Electrophysiology, Cleveland Clinic, Heart and Vascular Institute, Cleveland, Ohio 44195, USA
    Heart Rhythm 7:1567-71. 2010
    ..Pacemaker-requiring bradyarrhythmias after cardiac transplantation are common, and rarely can lead to sudden cardiac death. Prior outcomes studies have been limited to single-center data...
  8. doi request reprint Incidence, management, and outcomes of the arteriovenous fistula complicating transvenous lead extraction
    Edmond M Cronin
    Section of Electrophysiology and Pacing, Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland, Ohio
    Heart Rhythm 11:404-11. 2014
    ..An arteriovenous (AV) fistula is an infrequently reported complication of transvenous lead extraction (TLE), but may be under-recognized...
  9. ncbi request reprint Incidence, indications, risk factors, and survival of patients undergoing cardiac implantable electronic device implantation after open heart surgery
    Newton B Wiggins
    Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Cleveland Clinic, Sydell and Arnold Miller Heart and Vascular Institute, 9500 Euclid Avenue, Mail Code J3, Cleveland, OH 44195, USA
    Europace . 2016
    ..We aimed to evaluate the incidence, indications, and risk factors for postoperative CIED implantation. We also assessed survival of these patients compared with a non-device group...
  10. doi request reprint Transvenous extraction of implantable cardioverter-defibrillator leads under advisory--a comparison of Riata, Sprint Fidelis, and non-recalled implantable cardioverter-defibrillator leads
    Michael P Brunner
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio
    Heart Rhythm 10:1444-50. 2013
    ..Comparative safety and efficacy associated with transvenous lead extraction (TLE) of recalled and non-recalled implantable cardioverter-defibrillator (ICD) leads has not been well characterized...
  11. doi request reprint The impact of changing antiseptic skin preparation agent used for cardiac implantable electronic device (CIED) procedures on the risk of infection
    Mohammed Qintar
    Department of Internal Medicine, Cleveland Clinic, Cleveland, Ohio
    Pacing Clin Electrophysiol 38:240-6. 2015
    ..Recent data suggested a relationship between the antiseptic agent used for skin preparation at time of CIED procedure and risk for infection...
  12. doi request reprint Improved survival among ventricular assist device recipients with a concomitant implantable cardioverter-defibrillator
    Daniel J Cantillon
    Cleveland Clinic, Sydell and Arnold Miller Family Heart and Vascular Institute, Cleveland, Ohio 44195, USA
    Heart Rhythm 7:466-71. 2010
    ..It is unknown whether implantable cardioverter-defibrillator (ICD) detection and therapy can extend survival in the VAD population...
  13. pmc Catheter Ablation for Atrial Fibrillation in Heart Failure Patients: A Meta-Analysis of Randomized Controlled Trials
    Shadi Al Halabi
    The Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH
    JACC Clin Electrophysiol 1:200-209. 2015
    ..However, risks for both ablation and AADs are likely higher and success rates lower in patients with HF...
  14. pmc Cardiac Implantable Electronic Device Infection in Patients at Risk
    Khaldoun G Tarakji
    Heart and Vascular Institute, Cleveland Clinic, Ohio, US
    Arrhythm Electrophysiol Rev 5:65-71. 2016
    ..Data from non-randomised cohort studies have indicated that antibacterial envelope use can reduce the incidence of CIED infection by more than 80 % in high-risk patients and a randomised clinical trial is ongoing. ..
  15. doi request reprint Temporal onset, risk factors, and outcomes associated with stroke after coronary artery bypass grafting
    Khaldoun G Tarakji
    Heart and Vascular Institute, Department of Cardiovascular Medicine, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195, USA
    JAMA 305:381-90. 2011
    ..Stroke is a devastating and potentially preventable complication of coronary artery bypass graft (CABG) surgery. Better understanding of the timing and risk factors for stroke associated with CABG are needed...